Royal Marsden Nhs Foundation Trust
Clinical trials sponsored by Royal Marsden Nhs Foundation Trust, explained in plain language.
-
New drug combo shows promise for Hard-to-Treat breast cancer
Disease control OngoingThis phase 2 study tests whether adding the experimental drug ipatasertib to standard hormone therapy and a targeted drug can help people with a specific type of advanced breast cancer (ER+/HER2-) live longer without their cancer growing. The study includes 57 participants whose …
Phase: PHASE2 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated May 17, 2026 00:46 UTC
-
Bladder cancer patients get dual attack: immunotherapy plus radiation
Disease control OngoingThis early-stage trial tests the safety of combining an immunotherapy drug (pembrolizumab) with radiation therapy for people with advanced bladder cancer. About 34 participants will receive the drug before and during radiation, and then continue it for up to a year or longer. The…
Phase: PHASE1 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Melanoma survivors: could immunotherapy harm your heart years later?
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether melanoma survivors who received immunotherapy (immune checkpoint inhibitors) may have long-term heart problems, such as increased risk of heart attack. Researchers will invite 60 people who finished treatment 2 to 10+ years ago to undergo heart tests. …
Sponsor: Royal Marsden NHS Foundation Trust • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC